A Rare Complication of Atrial Septal Occluders: Diagnosis by Transthoracic Echocardiography

Dialetto, Giovanni; Covino, Franco Enrico; Scognamiglio, Giancarlo; Corte, Alessandro Della; Manduca, Sabrina; Iacono, Carola; Calabrò, Raffaele; Cotrufo, Maurizio

doi:10.1016/j.echo.2006.01.027

Cited by 8 publications

(6 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The post-procedure phase may include events as device displacement, embolism and arrhythmia. Displacement or prolapsed devices have been described related to the utilization of oversized occluder or unfavorable defect anatomy, causing erosion of surrounding structures, especially aortic root wall [7] .…”

Section: Introductionmentioning

confidence: 99%

Cost-Effectiveness of Procedures for Treatment of Ostium Secundum Atrial Septal Defects Occlusion Comparing Conventional Surgery and Septal Percutaneous Implant

Costa¹,

Santos²,

Sarti

et al. 2014

PLoS ONE

View full text Add to dashboard Cite

ObjectivesThe study performs a cost-effectiveness analysis of procedures for atrial septal defects occlusion, comparing conventional surgery to septal percutaneous implant.MethodsA model of analytical decision was structured with symmetric branches to estimate cost-effectiveness ratio between the procedures. The decision tree model was based on evidences gathered through meta-analysis of literature, and validated by a panel of specialists. The lower number of surgical procedures performed for atrial septal defects occlusion at each branch was considered as the effectiveness outcome. Direct medical costs and probabilities for each event were inserted in the model using data available from Brazilian public sector database system and information extracted from the literature review, using micro-costing technique. Sensitivity analysis included price variations of percutaneous implant.ResultsThe results obtained from the decision model demonstrated that the percutaneous implant was more cost effective in cost-effectiveness analysis at a cost of US$8,936.34 with a reduction in the probability of surgery occurrence in 93% of the cases. Probability of atrial septal communication occlusion and cost of the implant are the determinant factors of cost-effectiveness ratio.ConclusionsThe proposal of a decision model seeks to fill a void in the academic literature. The decision model proposed includes the outcomes that present major impact in relation to the overall costs of the procedure. The atrial septal defects occlusion using percutaneous implant reduces the physical and psychological distress to the patients in relation to the conventional surgery, which represent intangible costs in the context of economic evaluation.

show abstract

Section: Introductionmentioning

confidence: 99%

Cost-Effectiveness of Procedures for Treatment of Ostium Secundum Atrial Septal Defects Occlusion Comparing Conventional Surgery and Septal Percutaneous Implant

Costa¹,

Santos²,

Sarti

et al. 2014

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…Interference with mitral valve function and even structural damage to the mitral valve has been reported with atrial septal occluder devices [4–6]. To our knowledge, the case detailed in this report is the only case of HELEX device fracture resulting in perforation of a valve leaflet.…”

Section: Discussionmentioning

confidence: 85%

Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation

Qureshi

Mumtaz

Latson

2009

Cathet Cardio Intervent

View full text Add to dashboard Cite

One or more breaks in the wire frame of the HELEX Septal Occluder (W.L. Gore and Associates, Flaggstaff, Arizona) were identified in 5% of patients in the multicenter pivotal trial leading to FDA approval. Fractures of the perimeter frame have not previously been associated with any apparent deleterious clinical effects. We report a case in which the broken ends of wire at a frame fracture were located in a position that resulted in perforation of the anterior mitral valve leaflet. There was significant mitral regurgitation and the device was removed surgically. The possible etiologies and prevention of wire frame fractures are also discussed.

show abstract

“…[5][6][7] Subsequently, transthoracic echocardiography (TTE) has been implemented as the noninvasive tool of choice in the evaluation of symptomatic patients who have undergone transcatheter closure. 8 The larger body habitus of the adult may lead to poor acoustic windows precluding accurate device assessment. Advances in multislice computed tomography (MSCT) provide a unique method to assess complex intracardiac anatomy without the MSCT TO EVALUATE AMPLATZER-RELATED SYMPTOMS above-described limitations.…”

Section: Introductionmentioning

confidence: 99%

“…Although rare, device‐related complications unique to each device have been reported 5–7 . Subsequently, transthoracic echocardiography (TTE) has been implemented as the noninvasive tool of choice in the evaluation of symptomatic patients who have undergone transcatheter closure 8 . The larger body habitus of the adult may lead to poor acoustic windows precluding accurate device assessment.…”

Section: Introductionmentioning

confidence: 99%

Multislice Computed Tomographic Findings in Symptomatic Patients After Amplatzer Septal Occluder Device Implantation

Zaidi¹,

Cheatham²,

Raman³

et al. 2009

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

A Rare Complication of Atrial Septal Occluders: Diagnosis by Transthoracic Echocardiography

Cited by 8 publications

References 4 publications

Cost-Effectiveness of Procedures for Treatment of Ostium Secundum Atrial Septal Defects Occlusion Comparing Conventional Surgery and Septal Percutaneous Implant

Cost-Effectiveness of Procedures for Treatment of Ostium Secundum Atrial Septal Defects Occlusion Comparing Conventional Surgery and Septal Percutaneous Implant

Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation

Multislice Computed Tomographic Findings in Symptomatic Patients After Amplatzer Septal Occluder Device Implantation

Contact Info

Product

Resources

About